As the official scientific journal of DIA, TIRS is one of the top-rated benefits DIA Members receive. It provides a unique platform for researchers, regulators, industry, patient advocacy groups, and other healthcare decision-makers from around the globe to convert biomedical and regulatory science as well as health economic findings into practical solutions that advance human health.

Explore TIRS

Gregory Daniel

Editor-in-Chief

  
Gregory Daniel, PhD, MPH, is the Global Head of Public Policy at Eli Lilly & Company in Washington, D.C. Greg is also on the board of directors for the Innovation in Value Initiative (IVI), adjunct associate professor at the UNC Eshelman School of Pharmacy, and Visiting Expert at the Duke-NUS Centre of Regulatory Excellence, Duke-National University of Singapore Medical School. Formerly, he was deputy center director at the Duke-Margolis Center for Health Policy as well as fellow and managing director in the Center for Health Policy at the Brookings Institution. Greg received his PhD in pharmaceutical economics, policy, and outcomes from the University of Arizona, and an MPH, MS, and BS in Pharmacy from The Ohio State University.
Editorial Board

  • Theresa Allio


    Advanced Accelerator Applications

  • Josephine Babiarz


    Associate Professor , MCPHS University

  • Greg Ball

    Associate Editor
    Senior Principal Biostatistician, Merck & Co., Inc.

  • David R. Bristol


    President, Statistical Consulting Services Inc

  • Jonca Bull

    Associate Editor
    Vice President, Regulatory Consulting, PPD

  • Joseph Cappelleri


    Executive Director of Biostatistics, Pfizer Inc

  • Iraj Daizadeh

    Associate Editor
    Pfizer, Inc.

  • Richard O. Day

    Associate Editor
    Professor of Clinical Pharmacology; University of New South Wales, Medicine, St. Vincent's Hospital

  • Joseph A DiMasi


    Director, Economic Analysis and Research Associate Professor , Tufts Center for the Study of Drug Development

  • Todd Durham


    Durham Statistical Consulting LLC

  • Kevin Haynes

    Associate Editor
    Director of Clinical Epidemiology, HealthCore Inc.

  • Alan M Hochberg


    Principal Scientific Enablement Director, F. Hoffmann- La Roche

  • Lisa Kammerman

    Associate Editor
    Regulatory Statistics and PRO Consultant, Kammerman Consulting, LLC

  • Gracie Lieberman

    Associate Editor
    Senior Director Regulatory Policy, Genentech, A Member of the Roche Group

  • Wendy Louise Lipworth


    Senior Research Fellow, Centre for Values, Ethics and the Law in Medicine, University of Sydney

  • Nicole Mahoney

    Associate Editor
    Executive Director, Regulatory Policy and Intelligence, Novartis

  • Munish Mehra

    Associate Editor
    Executive Director, Tigermed

  • Shunsuke Ono


    Associate Professor, Laboratory of Pharmaceutical Regulatory Science, The University of Tokyo

  • Peter J. Pitts


    President, Center for Medicine in the Public Interest (CMPI)

  • Ronald Portman


    Executive Director, Pediatric Development, Science and Innovation, Clinical Development & Analytics, Novartis Pharmaceuticals Corporation

  • Estelle Russek-Cohen

    Associate Editor
    Senior Advisor, Office of Biostat, FDA

  • Ramses Sadek


    Professor of Biostatistics and Director GCC Biostatistics Core, Georgia Cancer Center at Augusta University

  • Rick Turner

    Editor Emeritus
    Expert Consultant, DRT Strategies, Inc.

  • Richard C. Zink

    Associate Editor
    Vice President, Data Management, Biostatistics, and Statistical Programming, Lexitas Pharma Services
Explore Editorial Boards